17-(Amino-PEG6-ethylcarbamoyl)heptadecanoic acid
This product is a PEGylated fatty acid derivative containing a terminal amino group, a carboxylic acid, and a PEG6 spacer, specifically offering both hydrophilic and lipophilic properties for versatile bioconjugation and drug delivery applications.
Key Features and Benefits
-
Terminal Amine: Reacts with activated esters, acids, or isocyanates.
-
Carboxylic Acid: Forms stable amide linkages with amines.
-
PEG6 Spacer: Improves solubility, flexibility, and biocompatibility.
-
Lipid Tail: Anchors into liposomes, micelles, or hydrophobic carriers.
-
High Purity: Produced to ≥95% purity for reproducibility.
Applications
-
Lipid–PEG Conjugates: Functionalizes nanoparticles, liposomes, or micelles.
-
Bioconjugation: Couples proteins, peptides, or polymers.
-
Drug Delivery: Extends solubility and circulation time of therapeutics.
-
Surface Modification: Functionalizes hydrogels, polymers, or nanomaterials.
-
Membrane Studies: Supports receptor and lipid–protein interaction research.
Storage and Handling
-
Storage: Store at –20 °C in a sealed, desiccated container.
-
Handling: Prepare fresh solutions; avoid repeated freeze–thaw cycles.
17-(Amino-PEG6-ethylcarbamoyl)heptadecanoic acid unites a PEG spacer with a hydrophobic lipid tail, enabling dual functionality specifically in advanced drug delivery and nanotechnology.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.
